-
Je něco špatně v tomto záznamu ?
Dominant KPNA3 Mutations Cause Infantile-Onset Hereditary Spastic Paraplegia
C. Schob, M. Hempel, D. Safka Brozkova, H. Jiang, SY. Kim, NA. Batzir, N. Orenstein, T. Bierhals, J. Johannsen, A. Uhrova Meszarosova, JH. Chae, P. Seeman, M. Woidy, F. Fang, C. Kubisch, S. Kindler, J. Denecke
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
SCHO 1921/2-1
Deutsche Forschungsgemeinschaft
SPP1935
Deutsche Forschungsgemeinschaft
MEYS 8F20002
European Joint Programme on Rare Diseases
EJP RD COFUND-EJP N° 825575
European Union's Horizon 2020 research and innovation programme
DRO00064203
Ministerstvo Zdravotnictví Ceské Republiky
Seoul National University
PubMed
34564892
DOI
10.1002/ana.26228
Knihovny.cz E-zdroje
- MeSH
- alfa karyoferiny genetika MeSH
- dospělí MeSH
- fenotyp MeSH
- heterozygot MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mutace genetika MeSH
- předškolní dítě MeSH
- rodokmen MeSH
- sekvenování exomu metody MeSH
- spastická paraplegie dědičná genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: Hereditary spastic paraplegia (HSP) is a highly heterogeneous neurologic disorder characterized by lower-extremity spasticity. Here, we set out to determine the genetic basis of an autosomal dominant, pure, and infantile-onset form of HSP in a cohort of 8 patients with a uniform clinical presentation. METHODS: Trio whole-exome sequencing was used in 5 index patients with infantile-onset pure HSP to determine the genetic cause of disease. The functional impact of identified genetic variants was verified using bioinformatics and complementary cellular and biochemical assays. RESULTS: Distinct heterozygous KPNA3 missense variants were found to segregate with the clinical phenotype in 8 patients; in 4 of them KPNA3 variants had occurred de novo. Mutant karyopherin-α3 proteins exhibited a variable pattern of altered expression level, subcellular distribution, and protein interaction. INTERPRETATION: Our genetic findings implicate heterozygous variants in KPNA3 as a novel cause for autosomal dominant, early-onset, and pure HSP. Mutant karyopherin-α3 proteins display varying deficits in molecular and cellular functions, thus, for the first time, implicating dysfunctional nucleocytoplasmic shuttling as a novel pathomechanism causing HSP. ANN NEUROL 2021;90:738-750.
Department of Pediatrics Seoul National University College of Medicine Seoul Republic of Korea
Department of Pediatrics University Medical Center Hamburg Eppendorf Hamburg Germany
Institute of Human Genetics University Medical Center Hamburg Eppendorf Hamburg Germany
Pediatric Genetics Clinic Schneider Children's Medical Center of Israel Petah Tikva Israel
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003262
- 003
- CZ-PrNML
- 005
- 20220127150520.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ana.26228 $2 doi
- 035 __
- $a (PubMed)34564892
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Schob, Claudia $u Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 245 10
- $a Dominant KPNA3 Mutations Cause Infantile-Onset Hereditary Spastic Paraplegia / $c C. Schob, M. Hempel, D. Safka Brozkova, H. Jiang, SY. Kim, NA. Batzir, N. Orenstein, T. Bierhals, J. Johannsen, A. Uhrova Meszarosova, JH. Chae, P. Seeman, M. Woidy, F. Fang, C. Kubisch, S. Kindler, J. Denecke
- 520 9_
- $a OBJECTIVE: Hereditary spastic paraplegia (HSP) is a highly heterogeneous neurologic disorder characterized by lower-extremity spasticity. Here, we set out to determine the genetic basis of an autosomal dominant, pure, and infantile-onset form of HSP in a cohort of 8 patients with a uniform clinical presentation. METHODS: Trio whole-exome sequencing was used in 5 index patients with infantile-onset pure HSP to determine the genetic cause of disease. The functional impact of identified genetic variants was verified using bioinformatics and complementary cellular and biochemical assays. RESULTS: Distinct heterozygous KPNA3 missense variants were found to segregate with the clinical phenotype in 8 patients; in 4 of them KPNA3 variants had occurred de novo. Mutant karyopherin-α3 proteins exhibited a variable pattern of altered expression level, subcellular distribution, and protein interaction. INTERPRETATION: Our genetic findings implicate heterozygous variants in KPNA3 as a novel cause for autosomal dominant, early-onset, and pure HSP. Mutant karyopherin-α3 proteins display varying deficits in molecular and cellular functions, thus, for the first time, implicating dysfunctional nucleocytoplasmic shuttling as a novel pathomechanism causing HSP. ANN NEUROL 2021;90:738-750.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mutace $x genetika $7 D009154
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a spastická paraplegie dědičná $x genetika $7 D015419
- 650 _2
- $a sekvenování exomu $x metody $7 D000073359
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a alfa karyoferiny $x genetika $7 D028901
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hempel, Maja $u Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Safka Brozkova, Dana $u Neurogenetic Laboratory, Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Jiang, Huafang $u Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China
- 700 1_
- $a Kim, Soo Yeon $u Department of Genomics Medicine, Rare Disease Center, Seoul National University Hospital, Seoul, Republic of Korea
- 700 1_
- $a Batzir, Nurit Assia $u Pediatric Genetics Clinic, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel
- 700 1_
- $a Orenstein, Naama $u Pediatric Genetics Clinic, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel
- 700 1_
- $a Bierhals, Tatjana $u Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Johannsen, Jessika $u Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Uhrova Meszarosova, Anna $u Neurogenetic Laboratory, Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Chae, Jong-Hee $u Department of Genomics Medicine, Rare Disease Center, Seoul National University Hospital, Seoul, Republic of Korea $u Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea
- 700 1_
- $a Seeman, Pavel $u Neurogenetic Laboratory, Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Woidy, Mathias $u Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Fang, Fang $u Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China
- 700 1_
- $a Kubisch, Christian $u Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Kindler, Stefan $u Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Denecke, Jonas $u Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 773 0_
- $w MED00000428 $t Annals of neurology $x 1531-8249 $g Roč. 90, č. 5 (2021), s. 738-750
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34564892 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150516 $b ABA008
- 999 __
- $a ok $b bmc $g 1750886 $s 1154411
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 90 $c 5 $d 738-750 $e 20211014 $i 1531-8249 $m Annals of neurology $n Ann Neurol $x MED00000428
- GRA __
- $a SCHO 1921/2-1 $p Deutsche Forschungsgemeinschaft
- GRA __
- $a SPP1935 $p Deutsche Forschungsgemeinschaft
- GRA __
- $a MEYS 8F20002 $p European Joint Programme on Rare Diseases
- GRA __
- $a EJP RD COFUND-EJP N° 825575 $p European Union's Horizon 2020 research and innovation programme
- GRA __
- $a DRO00064203 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $p Seoul National University
- LZP __
- $a Pubmed-20220113